[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"autologous-serum-eye-drops\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:autologous-serum-eye-drops":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100615675",false,"NCT07295691","Autologous Serum Eye Drops in Dry Eye Syndrome","Autologous Serum Eye Drops in Dry Eye Syndrome: Clinical Efficacy and Safety Evaluation","Inclusion Criteria:\n\n* Children aged less than 18 years.\n* Both sexes.\n* Diagnosed with moderate to severe dry eye syndrome (DES) refractory to artificial tears.\n\nExclusion Criteria:\n\n* Active ocular infection.\n* Recent ocular surgery.\n* Systemic immunosuppressive therapy.\n* History of allergy to blood-derived products.","ALL","18 Years",{"count":18,"type":19},70,"ESTIMATED","INTERVENTIONAL",[22],"NA","This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.",[25,26],"Autologous Serum Eye Drops","Dry Eye Syndrome","RECRUITING","2025-12-06",{"date":30,"type":31},"2025-12-22","ACTUAL",{"date":33,"type":31},"2025-09-01",{"date":35,"type":19},"2025-12-31",{"name":37,"class":38},"The General Authority for Teaching Hospitals and Institutes","NETWORK",""]